Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Possible Wrong Doings...Optymystic

Other business opportunities? PTSC seemed to be a great business opportunity unless Swartz had good inside information that the J's settlement would be for very little. Remember we had to wait until the Q to get an idea of what the settlement was with the J's. How many shares did Swartz unload during that period when other investors were anticipating a larger settlement and purchased shares in anticipation?

If you were S&L, would you keep all your proverbial eggs in the PTSC "basket", or release funds for diversification?

Perhaps the only information they needed to prompt the selling was a knowledge of the USPTO re-examination process?

The filings show S&L holdings.

.

.

Be well

Share
New Message
Please login to post a reply